Oncotar 500mg Injection
Prescription Required
Product introduction
Oncotar 500mg Injection is used to treat some kinds of cancers of blood. It may be also used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.
Oncotar 500mg Injection is used to treat severe forms of a skin disease (psoriasis) and to treat several disorders of joint disorders leading to painful swelling and redness of the joints.
Oncotar 500mg Injection is used to treat severe forms of a skin disease (psoriasis) and to treat several disorders of joint disorders leading to painful swelling and redness of the joints.
Uses of Oncotar Injection
Benefits of Oncotar Injection
In Blood cancer
Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Oncotar 500mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side effects of Oncotar Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Oncotar
- Rash
- Skin ulcer
- Nausea
- Vomiting
- Hair loss
- Abdominal pain
- Anal ulcers
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Fever
- Infection
- Abnormal liver function
- Low blood platelets
- Mouth ulcer
- Pneumonia
- Sepsis
- Mouth sore
- Stomatitis (Inflammation of the mouth)
How to use Oncotar Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Oncotar 500mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Oncotar 500mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Oncotar 500mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Oncotar 500mg Injection may cause side effects which could affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Oncotar 500mg Injection is safe to use in patients with kidney disease. No dose adjustment of Oncotar 500mg Injection is recommended.
However, talk to your doctor if you have any underlying kidney disease.
However, talk to your doctor if you have any underlying kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Oncotar 500mg Injection in patients with liver disease. Please consult your doctor.
Because of the limited information, a cautious use of Oncotar 500mg Injection is recommended in patients with liver disease.
Because of the limited information, a cautious use of Oncotar 500mg Injection is recommended in patients with liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Oncotar 500mg Injection
₹495.0/Injection
Cytalon 500mg Injection
Celon Laboratories Ltd
₹485.71/injection
2% cheaper
Arasid 500mg Injection
Intas Pharmaceuticals Ltd
₹572/injection
16% costlier
Biobin 500mg Injection
Biochem Pharmaceutical Industries
₹488.57/injection
1% cheaper
Remcyta 500mg Injection
Alkem Laboratories Ltd
₹541.31/injection
9% costlier
Cybin PF 500mg Injection
Vhb Life Sciences Inc
₹619/injection
25% costlier
Quick tips
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
Fact Box
Chemical Class
Pyrimidine Nucleoside Analog
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Antimetabolites
Patient concerns
FAQs
Is Oncotar 500mg Injection a vesicant?
No. Oncotar 500mg Injection is not a vesicant (irritant) but should be handled with care.
Is Oncotar 500mg Injection ototoxic?
No. Ototoxicity is not reported with use of Oncotar 500mg Injection. However, please consult your doctor if you experience such a side effect.
Is Oncotar 500mg Injection cytotoxic?
Yes. Oncotar 500mg Injection is a cytotoxic drug.
Does Oncotar 500mg Injection cause hair loss?
Yes. Oncotar 500mg Injection may cause hair loss.
How does Oncotar 500mg Injection prevent DNA replication?
Oncotar 500mg Injection prevents deoxyribonucleic acid (DNA) replication by inhibiting the synthesis of DNA.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1698-700.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 947.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 343-44.
- Cytarabine. Sandwich, Kent: Pfizer Limited; 1999 [revised Nov. 2017]. [Accessed 26 Mar. 2019] (online) Available from:
- Drugs.com. Cytarabine Pregnancy and Breastfeeding Warnings. [Accessed 26 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Name: United Biotech Pvt Ltd
Address: FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present